Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1

Conditions

Sarcoma 2Osteosarcoma 1Hemangiosarcoma 1Adenocarcinoma of Lung 1

Interventions

tislelizumab 1spartalizumab 1sintilimab 1milademetan 1enzalutamide 1Pemetrexed 1Midazolam 1Letrozole 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fulvestrant 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × sintilimab × Sarcoma × Clear all
NCT04861948 2022-10-04

IBI188 Combination Therapy in Solid Tumors

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1 Terminated
9 enrolled
SarcomaThoracic

Adenocarcinoma of Lung, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡